BRCA1 and breast cancer: In another conceptual breakthrough, investigators at the Sanger Institute demonstrated that there are more than 20 different patterns of somatic mutation in cancer based on copy number aberrations and nucleotide substitution patterns, with a subset of these recurrently observed in breast cancer (APOBEC, BRCA1/2, Signature B) [20].